BindingDB logo
myBDB logout

BindingDB Data by Journal




PMIDDataArticle TitleCitationOrganizationSD Files Download
293488035Synthesis of a Chloroalkene Dipeptide Isostere-Containing Peptidomimetic and Its Biological Application.EBIACS Med Chem Lett 9: 6-10 (2018)Tokyo Medical and Dental University2D 3D TSV
2934880556Synthesis and SAR of 1,2,3,4-Tetrahydroisoquinoline-Based CXCR4 Antagonists.EBIACS Med Chem Lett 9: 17-22 (2018)Emory University2D 3D TSV
2934880732Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone Acetyltransferases.EBIACS Med Chem Lett 9: 28-33 (2018)AbbVie, Inc.2D 3D TSV
2934880835Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery.EBIACS Med Chem Lett 9: 34-38 (2018)Second Military Medical University2D 3D TSV
293488091Discovery of MK-8722: A Systemic, Direct Pan-Activator of AMP-Activated Protein Kinase.EBIACS Med Chem Lett 9: 39-44 (2018)Merck Research Laboratories2D 3D TSV
2934881117Disconnecting the Estrogen Receptor Binding Properties and Antimicrobial Properties of Parabens through 3,5-Substitution.EBIACS Med Chem Lett 9: 51-55 (2018)Longwood University2D 3D TSV
294567905Late-Stage Microsomal Oxidation Reduces Drug-Drug Interaction and Identifies Phosphodiesterase 2A Inhibitor PF-06815189.EBIACS Med Chem Lett 9: 68-72 (2018)Pfizer Inc.2D 3D TSV
2945679122Nonacidic Chemotype Possessing EBIACS Med Chem Lett 9: 78-83 (2018)Hiroshima International University2D 3D TSV
2945679242-Leucinyl Benzenesulfonamides as Structurally Simplified Leucyl-tRNA Synthetase Inhibitors.EBIACS Med Chem Lett 9: 84-88 (2018)Oxford Drug Design Ltd.2D 3D TSV
2945679372Synthesis of Novel Tetrahydroisoquinoline CXCR4 Antagonists with Rigidified Side-Chains.EBIACS Med Chem Lett 9: 89-93 (2018)Emory University2D 3D TSV
2945679445Discovery of 3,3'-Spiro[Azetidine]-2-oxo-indoline Derivatives as Fusion Inhibitors for Treatment of RSV Infection.EBIACS Med Chem Lett 9: 94-97 (2018)WuXi AppTec (Shanghai) Co., Ltd2D 3D TSV
2945679527Discovery of EBI-2511: A Highly Potent and Orally Active EZH2 Inhibitor for the Treatment of Non-Hodgkin's Lymphoma.EBIACS Med Chem Lett 9: 98-102 (2018)Shanghai Hengrui Pharmaceutical Co. Ltd.2D 3D TSV
2945679651Discovery of Tetralones as Potent and Selective Inhibitors of Acyl-CoA:Diacylglycerol Acyltransferase 1.EBIACS Med Chem Lett 9: 103-108 (2018)GlaxoSmithKline2D 3D TSV
2945679930From ROR?t Agonist to Two Types of ROR?t Inverse Agonists.EBIACS Med Chem Lett 9: 120-124 (2018)Fudan University2D 3D TSV
2945680047Discovery and in Vitro Optimization of 3-Sulfamoylbenzamides as ROMK Inhibitors.EBIACS Med Chem Lett 9: 125-130 (2018)Pfizer Inc.2D 3D TSV
2945680152Identification of Potent Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors Based on a Phenylimidazole Scaffold.EBIACS Med Chem Lett 9: 131-136 (2018)University Health Network2D 3D TSV
294568024HTS by NMR for the Identification of Potent and Selective Inhibitors of Metalloenzymes.EBIACS Med Chem Lett 9: 137-142 (2018)University of California-Riverside2D 3D TSV
2945680317Potent Inhibitors of Hepatitis C Virus NS3 Protease: Employment of a Difluoromethyl Group as a Hydrogen-Bond Donor.EBIACS Med Chem Lett 9: 143-148 (2018)Bristol-Myers Squibb2D 3D TSV
212862389Discovery of New Human A(2A) Adenosine Receptor Agonists: Design, Synthesis, and Binding Mode of Truncated 2-Hexynyl-4'-thioadenosine.EBIACS Med Chem Lett 9: 516-520 (2010)Ewha Womans University2D 3D TSV